Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Radiotherapie op basis van ‘midtreatment’ PET-CT
jun 2017 | Longoncologie, Radiotherapie